A) The ease of obtaining stem cells from adults. B) The lack of potential applications. C) The use of embryonic stem cells. D) The uncontroversial ethical implications.
A) Ignoring public opinions and concerns. B) Ethical guidelines and regulations. C) Speed of research progress above all else. D) Funding from private corporations only.
A) To address regulatory disparities and ensure ethical standards. B) To avoid sharing scientific breakthroughs. C) To hinder progress in the field. D) To eliminate competition among research institutions.
A) Providing expertise on ethical implications and considerations. B) Advocating for unrestricted research with no ethical oversight. C) Opposing all forms of medical research involving stem cells. D) Serving as decision-makers for all stem cell research projects.
A) Excluding patient advocates from the research process. B) Developing international policy guidance on stem cell research. C) Creating financial barriers to stem cell research. D) Promoting unregulated stem cell experimentation.
A) Pluripotent cells can only divide a limited number of times. B) There is no difference between the two types of stem cells. C) Pluripotent cells are more versatile than totipotent cells. D) Totipotent cells can develop into any type of cell, including embryonic tissues, while pluripotent cells can develop into almost any type of cell.
A) Create artificial intelligence using stem cells. B) Repair, replace, and regenerate damaged cells or tissues. C) Replace traditional medicine for all illnesses. D) Speed up the aging process in patients.
A) To only focus on economic factors. B) To ignore public opinions and concerns. C) To prioritize scientific progress over societal implications. D) To address diverse views on ethics, religious beliefs, and values that impact policy decisions. |